Max Salganik

Max Salganik is an accomplished healthcare professional with extensive experience in medical affairs and companion diagnostics. Currently serving as Senior Director of Companion Diagnostics at Syros Pharmaceuticals since May 2022, Max previously held leadership roles at Biotheranostics, A Hologic Company, where the title held included Director of Medical Affairs. Prior to those positions, Max worked at Biotheranostics, Inc. in various capacities including Associate Director of Medical Affairs and Medical Science Liaison. Max's early career involved a postdoctoral fellowship at UNC Lineberger Comprehensive Cancer Center, focusing on gene therapy applications, as well as a regulatory affairs internship at Duke University. Max's academic background includes a Ph.D. in Biomedical Sciences from the University of Florida and a Bachelor’s degree in Biotechnology from Rutgers University.